Literature DB >> 9814400

Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia.

N Tsarouhas1, K N Shaw, R L Hodinka, L M Bell.   

Abstract

OBJECTIVE: To determine if intramuscular (IM) penicillin is more effective than oral (PO) amoxicillin in the early outpatient treatment of pediatric patients with presumed bacterial pneumonia.
METHODS: Prospective, randomized, evaluator-blinded, clinical trial.
SETTING: Pediatric emergency department (ED) of an urban children's hospital. PATIENTS: ED patients with radiographically confirmed pneumonias managed as outpatients. Patients with chronic illnesses, wheezing, allergy to amoxicillin or penicillin, recent antibiotic therapy, or concurrent diagnosis of another febrile illness were excluded.
INTERVENTIONS: Patients received either a two-day supply of PO amoxicillin (50 mg/kg/day divided tid), or an IM injection of procaine penicillin G (PPG) (50,000 units/kg). They had a complete blood count (CBC), blood culture, and nasopharyngeal swab for viral culture done at initial visit. They returned in 24 to 36 hours for reevaluation. OUTCOME MEASURES: The main measures were temperature, respiratory rate, and general appearance score; additional measures were accessory muscle use, pulse oximetry, parental report of activity/oral intake.
RESULTS: One hundred seventy patients were enrolled. There were no significant differences between the two groups at initial or follow-up visits with respect to temperature, respiratory rate, accessory muscle use, pulse oximetry, or parental reports of activity level and oral intake. Only in the general appearance of children less than two years of age did there appear to be a difference (P = 0.03). When subanalysis excluded patients with positive viral studies (n = 17) or chest x-rays "reread" by an attending pediatric radiologist as "no infiltrate" (n = 29), this difference disappeared (P = 0.10). Three patients in the PO group, and five in the IM group failed by all three main outcome measures (P = 1.00). Four patients in the PO group, and five in the IM group were hospitalized at the follow-up visit (P = 1.00).
CONCLUSION: There does not appear to be a significant difference between PO amoxicillin and IM penicillin in the early outpatient treatment of pediatric patients with presumed bacterial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814400

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  14 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 2.  Oral antibiotics versus parenteral antibiotics for severe pneumonia in children.

Authors:  M X Rojas; C Granados
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

4.  Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia.

Authors:  Feyzullah Cetinkaya; Abdulkadir Gogremis; Gunsel Kutluk
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

5.  Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia.

Authors:  Lilliam Ambroggio; Matthew Test; Joshua P Metlay; Thomas R Graf; Mary Ann Blosky; Maurizio Macaluso; Samir S Shah
Journal:  Pediatr Pulmonol       Date:  2015-09-14

6.  Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.

Authors:  Maria Atkinson; Monica Lakhanpaul; Alan Smyth; Harish Vyas; Vivienne Weston; Jabulani Sithole; Victoria Owen; Katharine Halliday; Helen Sammons; Jo Crane; Narayan Guntupalli; Lynda Walton; Titus Ninan; Anu Morjaria; Terence Stephenson
Journal:  Thorax       Date:  2007-06-13       Impact factor: 9.139

Review 7.  Antibiotics for community-acquired pneumonia in children.

Authors:  Rakesh Lodha; Sushil K Kabra; Ravindra M Pandey
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

8.  Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia.

Authors:  Angela L Myers; Matthew Hall; Derek J Williams; Katherine Auger; Joel S Tieder; Angela Statile; Karen Jerardi; Lauren McClain; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

Review 9.  Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies.

Authors:  Gerdien A Tramper-Stranders
Journal:  Paediatr Respir Rev       Date:  2017-07-15       Impact factor: 2.726

10.  Efficacy of high doses of oral penicillin versus amoxicillin in the treatment of adults with non-severe pneumonia attended in the community: study protocol for a randomised controlled trial.

Authors:  Carl Llor; Javier Arranz; Rosa Morros; Anna García-Sangenís; Helena Pera; Joan Llobera; Mireia Guillén-Solà; Eugenia Carandell; Jesús Ortega; Silvia Hernández; Marc Miravitlles
Journal:  BMC Fam Pract       Date:  2013-04-17       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.